Pharmacogenomics of response to statin treatment and susceptibility to statin-induced adverse drug reactions in Asians: a scoping review Cover

.blurhash-client-img { display: none !important; }

Pharmacogenomics of response to statin treatment and susceptibility to statin-induced adverse drug reactions in Asians: a scoping review

Asian Biomedicine

Volume 17 (2023): Issue 3 (June 2023)

By: Hui-Yin Yow, Sharina Hamzah, Nusaibah Abdul Rahim and Vijayaprakash Suppiah

Open Access

|Oct 2023

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/abm-2023-0050 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415

Journal RSS Feed

Language: English

Page range: 95 - 114

Published on: Oct 9, 2023

Published by: Chulalongkorn University

In partnership with: Paradigm Publishing Services

Publication frequency: 6 issues per year

Keywords:

HMG-CoA reductase inhibitors,

HMG-CoA statins,

pharmacogenomics

Related subjects:

Assistive professions, nursing,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Clinical medicine, other

© 2023 Hui-Yin Yow, Sharina Hamzah, Nusaibah Abdul Rahim, Vijayaprakash Suppiah, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous article Volume 17 (2023): Issue 3 (June 2023)Next article